An Open Label Study of the Effects of Eculizumab in CD59 Deficiency
This study is currently recruiting participants.
Verified April 2012 by Hadassah Medical Organization
Sponsor:
Hadassah Medical Organization
Information provided by (Responsible Party):
Mevorach Dror, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01579838
First received: February 23, 2012
Last updated: April 17, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |